首页> 外文期刊>Neuro-ophthalmology >Amiodarone-associated Optic Neuropathy-A Clinical Criteria-based Diagnosis?
【24h】

Amiodarone-associated Optic Neuropathy-A Clinical Criteria-based Diagnosis?

机译:胺碘酮相关视神经病变 - 基于临床标准的诊断?

获取原文
获取原文并翻译 | 示例
           

摘要

Amiodarone-associated optic neuropathy (AAON) is a controversial diagnosis with possible impact on vital cardiac therapy decisions. This retrospective case series aims for application of distinguishing features of AAON versus non-arteritic ischaemic optic neuropathy (NAION): Bilaterality, mode of onset, degree of optic nerve dysfunction, structure of uninvolved disc (unilateral cases), and systemic toxic effects. Applying these criteria to patients with disc swelling under amiodar-one, the authors identified four unilateral disc swellings, one with NAION-typical features only and three with one or more NAION-atypical features. All three sequential and six bilateral cases showed one or more NAION-atypical features. The 12 cases highlight the persisting diagnostic dilemma arising from diversity of presentation, lack of plausible pathomechanism, and controversial existence of the entity itself.
机译:胺碘酮相关视神经病变(AAON)是一种有争议的诊断,可能对重要的心脏治疗决策产生影响。 这种回顾性案例系列旨在应用AAON与非动脉缺血视神经神经病变(NAION)的区别特征:双侧,发病方式,视神经功能障碍程度,未凝固光盘结构(单侧案例)和全身毒性作用。 本作者将这些标准应用于AMIODAR-ON下的椎间盘肿胀患者,发现了四个单侧盘肿胀,一个单侧椎间盘突出,仅为NAION - 典型的特征,其中三个具有一个或多个NAION-非典型特征。 所有三个顺序和六种双侧病例都显示出一个或多个NAION-非典型特征。 12例突出了持续的诊断困境,呈现出呈现,缺乏合理的土地机制和实体本身的争议存在。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号